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Abstract 
Background: Twin pregnancies are at higher risks of velamentous cord 
insertion (VCI) and vasa previa (VP). In-vitro fertilization (IVF) is an additional 
direct risk factor of abnormal cord insertion and thus the incidence of VP is likely 
to increase over the next decades.  
 Objective: Our aim was to evaluate the specific challenges associated with 
the prenatal diagnosis and management of VP in twins.  
Study design:  We searched our database for twin pregnancies diagnosed 
with VP and managed antenatally using measurements of cervical length (CL) 
and performed a systematic review of articles which correlated prenatal 
diagnosis of VP in twins and pregnancy outcome. Data sources: PubMed and 
MEDLINE were searched for article published between the first prenatal 
ultrasound description of VP in 1987 and 20 October 2016 using medical 
subject heading (MeSH) terms, keywords and their combination including “vasa 
previa”, “velamentous insertion of the cord”, “velamentous vessel”, 
“membranous umbilical vessels”, “twin pregnancy”, “multiple pregnancy”, 
“placenta previa” “In vitro fertilization pregnancy”, “succenturiate lobe”, “low-
lying placenta” and “bilobate placenta” as related to “sonography”, “ultrasound 
diagnosis”, “prenatal diagnosis” and “colour Doppler”. Study eligibility criteria: 
The primary eligibility criteria were articles which correlated prenatal ultrasound 
imaging of VP and pregnancy outcome. The secondary outcome was the use of 
CL in the management of twin pregnancies diagnosed antenatally with VP. 
Study appraisal and synthesis methods: The final selection included 3 case 
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report series, 9 retrospective cohort studies and 1 retrospective case-control 
study of VP diagnosed prenatally and confirmed at birth in twin pregnancies. 
Results: The search of our databases identified six cases of dichorionic-
diamniotic (DCDA) twins and 1 case of monochorionic-diamniotic (MCDA) twins 
diagnosed prenatally with VP between 22 and 29 weeks and managed using 
CL. Two cases were delivered by emergency because of rapid changes in CL in 
one and bleeding on placenta praevia in the other at 33 weeks and 30 weeks, 
respectively. The systematic review identified data on 56 cases. The incidence 
of twin pregnancies diagnosed antenatally with VP in the cohort and case-
control studies was 11.0%. Data on chorionicity was available in only 34 cases 
and CL measurements were used by only the authors of two case reports and 
four cohort studies. VCI was the most common additional ultrasound findings in 
twins presenting with VP in both our series and the systematic review. 
Conclusions:  VP is associated with specific prenatal and obstetric 
complications with different outcomes in singletons compared to twins. Data on 
the diagnosis and management of VP in twin pregnancies are limited but there 
is enough evidence to warrant guidelines for targeted screening. To enable the 
development of efficient management protocols tailored to the need of individual 
cases, future studies of the screening, diagnosis and management of VP should 
be prospective and multicentric with detailed data on twins including chorionicity 
and use of CL. 
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Introduction 
A vasa previa (VP) describes an aberrant chorionic vessel directly connected to 
the umbilical cord circulation but running between the amniotic and the 
chorionic layers of the placental free membranes below the fetal presenting 
part.1 VP are classically separated into 2 different categories: type I which 
describes vessels that connect a velamentous cord to the main placental mass 
and type II which describes vessels running between one or more accessory 
lobes of the placenta.1 The classic presentation of undiagnosed VP in labour is 
the presence of painless vaginal bleeding. This occurs mainly when the cervix is 
effaced and dilated and the membranes rupture spontaneously or are ruptured 
artificially. It can lead to rapid fetal exsanguination and death1-5 and the 
perinatal mortality of undiagnosed VP has been reported to be as high as 60%.6  
The incidence of VP has been reported to range between in 1 in 1200 to 
1 in 5000 pregnancies but the condition may have been under-reported.1-5 A 
recent systematic review of 10 cohort studies found that the incidence of VP is 
0.6 per 1000 pregnancies.7 Approximately 90% of women presenting with a VP 
also have a velamentous cord insertion (VCI) and 3-4% of women presenting 
with a VCI have a VP.8 Unlike the single umbilical artery cord which is routinely 
recorded by midwives at birth, these cord anomalies are only recorded when 
associated with perinatal complications and the placental is examined by a 
pathologist.  
The pathophysiology of VP and VCI is uncertain but it has been linked to 
an abnormal development of the definitive placenta. Both cord anomalies are 
more common in bilobated placenta, succenturiate or accessory placenta and 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
5 
 
5 
low-lying placenta.1-8 VCI and VP type I are also more common in twin 
pregnancies and monochorionicity doubles the risk for VCI compared to 
dichorinicity.11,12 Maternal smoking has been recently reported as a risk factor 
for VCI and thus potentially of VP.13 Assisted reproduction technology (ART) 
and in vitro fertilization (IVF) in particular is associated with a higher incidence 
of abnormally shaped placenta, placenta previa and cord insertion outside the 
placental chorionic plate.7,14 It has been hypothesized these placental and cord 
anomalies could be due to the inadequate orientation of the IVF blastocyst at 
the time of implantation or to a higher incidence of vanishing twins in IVF than in 
spontaneous twins.10,14-18 The incidence of VP has been reported to be as high 
as one in 300 pregnancies conceived after ART.7,14 These data suggest that the 
incidence of VP in both singleton and multiple pregnancy gestations is likely to 
increase in the next decade with the increase use of ART worldwide.  
 Recent national guidelines, expert reviews and decision analysis study 
on the management of VP have recommended delivery of all women presenting 
with VP between 34-36 weeks of gestation but none provide with a specific 
algorithm for twins.3-6,8,19 Twin pregnancies are associated with specific 
obstetric complications and in particular with a higher incidence of premature 
delivery.20 Like singletons, twins presenting with VP have very poor outcomes 
when antenatal diagnosis is not made before the onset of labour.21 Previous 
studies and reviews have not identified twin pregnancies diagnosed with VP 
during pregnancy as requiring a different management strategy. We present a 
case series and a systematic review of the literature of twin pregnancies 
diagnosed prenatally with VP. Our aim is to evaluate the role of ultrasound 
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imaging in optimizing the management of individual cases of twins diagnosed 
antenatally with VP and in supporting the development of the corresponding 
clinical guidelines. 
 
Material and Methods 
 
Case series 
The location of the placental insertion of the umbilical cord is included in our 
routine mid-trimester transabdominal fetal detailed anatomy ultrasound protocol 
in targeted cases i.e. in cases of low-lying placenta, bilobate placenta, 
succenturiate lobed placenta, multiple pregnancies and IVF conceptions. When 
a VCI is identified on transabominal ultrasound, a transvaginal scan (TVS) is 
performed to exclude a VP. Our units have collaborated on the use of cervical 
length (CL) in the management of twin pregnancies22,23 and are using similar 
protocols based on national and international guidelines for the prenatal 
diagnosis of VP. Asymptomatic women presenting with VP are followed-up 
every 2 weeks, from 26-28 weeks until delivery, for fetal growth and wellbeing 
and with TVS for CL and VP position. The timing of delivery is scheduled 
according to changes in CL and/or clinical symptoms (mainly uterine 
contractions and/or vaginal bleeding), following a course of corticosteroids. 
When the CL remains stable with normal fetal development and there are no 
clinical symptoms delivery is planned at around 36 weeks. 
Systematic review information sources and search strategy  
The search protocol was designed a priori and registered on PROSPERO 
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(#50164). We performed an electronic search of the literature in PubMed and 
MEDLINE and selected relevant studies that have been published between the 
first prenatal ultrasound description of VP by Gianopoulos et al.24 in 1987 and 
20 October 2016. The search was achieved using medical subject heading 
(MeSH) terms, keywords and their combination including “vasa previa”, 
“velamentous insertion of the cord”, “velamentous vessel”, “membranous 
umbilical vessels”, “twin pregnancy”, “multiple pregnancy”, “placenta previa” “In 
vitro fertilization pregnancy”, “succenturiate lobe”, “low-lying placenta” and 
“bilobate placenta” as related to “sonography”, “ultrasound diagnosis”, “prenatal 
diagnosis” and “colour Doppler”.  
We included all cohort studies and case reports that described the 
prenatal diagnosis of VP in women presenting with a twin pregnancy (Figure 1). 
Systematic review eligibility criteria 
The primary eligibility criteria were articles which correlated prenatal ultrasound 
imaging of VP and pregnancy outcome. The secondary outcome was the use of 
CL in the management of twin pregnancies diagnosed antenatally with VP.  Two 
authors (EJ and RM) independently assessed inclusion criteria, data extraction 
and analysis. 
Systematic review study selection  
The initial database search provided 44 reports and cross-referencing provided 
an additional two reports, making a total of 43 records after removal of three 
duplicates (Figure 1). Out of the 43 records screened, 13 did not included data 
on prenatal ultrasound imaging of VP and were therefore excluded. After the 
second selection, letters with no description of the case, commentaries and 
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reviews were excluded. A further six reports where antenatal ultrasound was 
performed but cases of VP were only diagnosed at delivery were further 
excluded leaving 13 reports for the final analysis.  
Statistical analysis 
Numerical data from the case series and systematic review were analysed 
using the StatGraphic data analysis and statistical software package 
(Manugistics, Rockville, MD). 
 
Results 
Case series 
The search of our databases identified seven sets of twins diagnosed prenatally 
with VP, followed-up using our standard protocol and confirmed at birth by 
detailed pathologic examination. Table 1 presents the clinical data and outcome 
of these cases. There were six cases of dichorionic-diamniotic (DCDA) twins 
and 1 case of monochorionic-diamniotic (MCDA) twins (case 7). Five DCDA 
cases were conceived following IVF. The mean (SD) gestational at time of 
diagnosis was 26+5 (3+1) weeks. In five cases, a VCI was detected on 
transabdominal ultrasound at the mid-trimester examination or during a fetal 
growth scan follow-up. In the other two cases, the diagnosis of VP was made at 
the time of the first CL measurement. In five cases, the CL remained >25 mm 
and the patients were managed conservatively without hospitalization. In one 
case, the CL was found to be 10 mm at 32+6 weeks (case 5) and an 
emergency CS performed the next day because of vaginal bleeding.  One case 
was complicated by placenta previa accreta (case 6) for which an emergency 
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caesarean delivery was performed at 30+3 weeks because of major vaginal 
bleeding. In the case of MCDA twins (case 7), the cord of the presenting twin 
(fetus 1) was inserted half-way between the lower placental edge and the 
cervix. On TVS, there was a large VP above the internal os with non-pulsatile 
flow on Doppler imaging (Figures 2 A & B). This venous VP could be traced 
back to the area of the VCI with colour mapping. No VP arteries were found. 
The CL was stable on follow-up scans and there was no ultrasound evidence of 
twin-to-twin transfusion syndrome (TTTS) but a 20% discrepancy in estimated 
fetal weight was noted from 32+4 weeks and an elective caesarean delivery 
was performed at 35+1 weeks. The mean (SD) gestational at the time of 
delivery was 34.2 (2.1) weeks. 
Systematic review report characteristics 
 We found data on 56 cases of VP diagnosed prenatally in twin pregnancies, 
confirmed at birth and included in 3 case report series,25-27 9 retrospective 
cohort studies6,17,28-34 and 1 retrospective case-control study35 (Table 2). The 
incidence of twin pregnancies diagnosed with VP on ultrasound during 
pregnancy for which ultrasound data and post-natal confirmation was available 
in the cohort and case-control studies was 11.0% (48 cases of twins for 438 
pregnancies diagnosed with VP).  
Systematic review synthesis of results 
Out of the 34 cases for which data on chorionicity were available, there were 19 
DCDA and 15 MCDA twin pregnancies. In one case report, the diagnosis of VP 
was made at the time of laser photocoagulation of communicating anastomoses 
in a MCDA twin pregnancy complicated by twin-twin transfusion syndrome 
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(TTTS).27 The authors of two case reports26,27 and of four cohorts31-34 described 
the use of CL measurements in their management of twin pregnancies 
presenting with VP on antenatal ultrasound.  
Only two authors of cohort studies included perinatal data on individual 
twin pregnancies that were diagnosed by ultrasound antenatally.29,31 Detailed 
measurements of CL were only provided in two cases in a cohort series31 and in 
one case report.27 Table 3 displays the baseline perinatal characteristics of 12 
cases of VP diagnosed antenatally and verified by clinical documentation at 
birth and/or a pathology report. In seven cases, there was information on 
additional ultrasound findings including a low-lying placenta and VCI in three 
cases25,26 and VCI alone in two cases.17,28 The mean (SD) gestational at the 
time of diagnosis was 23+6 (7+1) weeks. Information on the mode of delivery 
was available in eight cases including five elective and three emergency 
caesarean sections, two for premature rupture of the membranes27,28 and one 
for preeclampsia.17 The mean (SD) gestational at time of delivery was 32+6 
(3+5) weeks. The neonatal outcome of the corresponding 24 fetuses including 
two stillbirths and two neonatal deaths.29,31 
 
Discussion 
 
Main findings 
Our review indicates a total incidence of 11.0% of twin pregnancies in cohort 
studies on the prenatal diagnosis of VP. Our case series and systematic review 
confirm that like for singletons, the outcome for twin fetuses and neonates is 
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excellent when the VP is diagnosed antenatally. Determination of chorionicity 
and serial measurements of CL can provide individualised management 
pathways for twin pregnancies with VP and in particular in the timing of delivery 
or the need for emergent caesarean section before a planned delivery around 
36 weeks.  
 
Comparison with existing literature 
A 97% survival rate has been reported in cases of VP diagnosis prenatally 
compared to only 44% when the diagnosis was made during delivery.6 A recent 
systematic review of ultrasound in the diagnosis of VP including two prospective 
and six retrospective cohort studies out of which six had a poor methodology 
found prenatal detection rates ranging between 53% (10/19) to 100% for a total 
of 442,633 women, including 138 cases of VP.36 Four out of the eight studies 
used TVS for primary assessment, while the remaining four studies used 
transabdominal ultrasound and only used TVS when a VP was suspected on 
the transabdominal scan. The gestational age at the time of diagnosis was 
reported in five studies and ranged from 18+0 to 26+6 weeks. The data of twin 
pregnancies were not analyzed separately by the authors. The accuracy of 
ultrasound at 9-13 weeks' gestation in screening for VP was evaluated 
prospectively in case-control study.37 However, the definitive placenta is only 
fully formed by 10-11 weeks of gestation1 making it difficult in many cases to 
predict the final position of the umbilical cord and to identify placental 
morphologic anomalies in particular in twins. The performance of ultrasound in 
screening for and diagnosing VP considered more efficient at around mid-
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gestation3-5,36 and the mean gestational age at diagnosis in twins, in our series 
and in the literature, was 26+5 and 23+6 weeks, respectively. 
Cases of VP in both singletons and twins described in the literature 
present a pulsatile flow velocity waveforms indicative of an arterial previa 
vessel.3-5,6,31 One of our case (case 7) presented with venous VP and the 
arteries were not visible on TVS color mapping (Figure 2B). We found no similar 
case described in the international literature. A venous VP could be easily 
mistaken for “free loop” of cord3 and thus in particular in this case it may be 
useful to trace the route of the vessel to the VIC and to demonstrate that it does 
not “move” with changing maternal position and/or between ultrasound 
examinations. 
Several studies have suggested that the majority of cases of VP can be 
suspected prenatally by routinely evaluating the placental cord insertion in 
pregnancies with low-lying placenta and the placental morphology.4,6-8, 29,38 The 
incidence of succenturiate lobes and other morphological placental anomalies is 
higher in twin pregnancies.1,11,39,40 A VCI of one of the umbilical cords is eight 
times more common in twins than in singletons. 39 The odd ratio for VP in 
pregnancies presenting with a bilobated placenta or with succenturiate lobe has 
been evaluated to be 22.11 in twin pregnancies.39 Five of the seven cases of 
our series (Table 1) and five out of the eight cases described in details in the 
literature (Table 3) presented with a VCI. One cases in our series and three in 
the literature also presented a low-lying placenta or placenta previa. Thus, the 
placental cord insertion should be documented at the second trimester scan in 
all twin pregnancies. 
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The largest study to date on the perinatal outcome of VP is based on a 
retrospective multicentric cohort of 155 women with VP diagnosed at the mid-
trimester scan and it included 50 (32.3%) cases associated with a bilobated or 
succenturiate lobed placentas and 95 (61%) with low-lying placenta.6 Only 
seven cases (4.5%) were twin pregnancies and the authors provided with no 
data on chorionicity and individual outcome. Overall only half of the cohort 
studies that are included in the present review provide detailed data on 
chorionicity (Table 2). Similarly, to singleton pregnancies, a ruptured VP in the 
presenting twin of a DC pair will lead to acute hemorrhage in the corresponding 
twin. By contrast, in MC twins, the acute hemorrhage in the presenting twin may 
also lead to acute blood shift and rapid exsanguination in the co-twin due to the 
presence of inter-twin placental vascular anastomoses. Van Steenis et al. 
reported recently a case of double fatal outcome in MC twins and reviewed 
similar cases published in the international literature since the first case reports 
in 1939.41 Including their case, there were three other recent cases reported in 
the last five years in the international literature but surprisingly none were 
diagnosed prenatally42-44 and were, therefore, not included in the present 
review.  
 
Clinical implications 
The ultimate management goal of confirmed VP prenatally is to deliver before 
labor and in particular before the rupture of membranes while minimizing the 
impact of iatrogenic prematurity. There is no consensus about the time of 
delivery in cases of confirmed VP and the currently low prevalence of prenatal 
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diagnosis of this condition precludes any prospective trials to evaluate the ideal 
timing. Data from a decision analysis study comparing 11 strategies for delivery 
timing in a patient with VP found that delivery between 34 and 36 weeks 
balances the risk of premature rupture of the membranes and subsequent fetal 
hemorrhage and death versus the risks of prematurity.19 This study did not 
differentiate between singleton and twin pregnancies. A cost-utility analysis 
based on a decision-analytic model comparing relevant strategies and life-long 
outcomes for mother and infant has shown that screening all twin pregnancies 
for VP with transvaginal ultrasound is cost-effective and has incremental cost-
effectiveness ratio of $5488 per quality-adjusted life-years gained.45 We suggest 
that in twins diagnosed with VP with uncomplicated antenatal course, to 
minimize the impact of prematurity the optimal timing for scheduled caesarean 
delivery is 36 weeks. 
A recent systematic review and meta-analysis of the association between 
placental implantation abnormalities including placenta previa, placenta accreta, 
VP, and VIC and preterm delivery in singleton gestations has found a perinatal 
death rate risk ratio of 4.52 (95% CI, 2.77-7.39) for VP.2 The associated 
complications of prematurity are, in many cases, the result of iatrogenic preterm 
birth in an effort to prevent stillbirth. Antenatal hospitalization to allow for closer 
surveillance for signs of labor in a unit with appropriate neonatal facilities has 
also been proposed for all pregnancies presenting with VP from 30-32 weeks of 
gestation3-5,31 but the evidence is weak and based on low-quality evidence.4 No 
specific data are available for twins pregnancies diagnosed with VP. 
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Twin pregnancies are at higher risks of preterm delivery and a recent 
retrospective cohort study of 441 women with twin pregnancies has found that 
integration of serial measurements of CL using a stepwise algorithm in 
asymptomatic women with twin gestations can improve the detection of women 
at risk of preterm birth.46 Women with VP in a MC twin pregnancy also require a 
regular follow-up to assess the risks of TTTS and thus determining the twin 
chorionicity is pivotal in the management of these high-risk pregnancies.  
 
Strengths and weaknesses 
This study provides data supporting the need to screen for VP in twin 
pregnancies in particular those resulting from IVF. A recent systematic review 
and meta-analysis has found no clear evidence of benefit from planned 
caesarean section for term twin pregnancies with leading cephalic 
presentation47 and thus for women opting for a vaginal birth it is essential to 
have exclude a VP antenatally. Our data also support the determination of 
chorionicity and use of transvaginal sonographic assessment of CL to evaluate 
the individual risk of premature delivery in twins presenting with VP. Overall our 
study is the first to highlights the need to incorporate these parameters in local 
protocols and national guidelines in the perinatal management of twins. The 
weakness of the study is its retrospective nature and the lack of specific details 
on twins in most cohort series. In twins diagnosed with VP antenatally in the 
literature, information on chorionicity was available in only 34 out of 56 (60.7%) 
cases and CL measurements used by only six authors out of 13 thus limiting the 
number of cases available for analysis.  
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Conclusions  
VP is associated with specific prenatal and obstetric complications with different 
outcomes in singletons compared to twins. It is important to make the diagnosis 
in the second trimester to allow preventative measures to be taken and avoid 
subsequent perinatal complications. There is enough evidence to warrant 
guidelines for targeted screening with TVS and colour Doppler in twin 
pregnancies to rule out VP, as the relative obstetric risk is significantly higher 
than in singletons. In twin pregnancies, the ultrasound follow-up should also be 
tailored according to chorionicity, changes in cervical length and clinical 
symptoms. Outpatient management is possible if there is no evidence of 
cervical shortening on TVS and there are no symptoms of bleeding or preterm 
uterine activity. Multicentric prospective VP screening studies with detailed data 
on twins including their chorionicity are required to develop more efficient 
management protocols tailored to the need of individual cases. 
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Figure legends 
Fig 1: Flow diagram showing the selection of reports included in the 
review. 
Fig 2: Transvaginal ultrasound scans: A) showing a large VP (arrow) 
above the internal os of the cervix (Cx) on color mapping; B) with non-
pulsatile flow on Doppler imaging (arrow). Consent was obtained from 
the patient for the use of these images. 
 
 
Table 1. Prenatal ultrasound data and outcome of 7 cases of twin pregnancies 
diagnosed with VP 
Case 
No. 
GA at 
diagnosis 
(wks + 
days) 
Other 
US 
findings 
Chorionicity- 
amnionicity 
CL (mm) at 
last TVS 
(GA wks + 
days) 
GA at 
delivery 
(wks + 
days)  
Outcome 
Mode of delivery 
Fetal sex & weight (g) 
1 28+2 None DCDA 30 (32+3) 36+1 ElCS M2810/M2850 
2 29+1 None DCDA 33 (32+5) 34+0 ElCS F2026/F2030 
3 29+2 VCI & 
SUA x2 
DCDA  38 (34+2) 35+0 ElCS M2040/M2240 
4 22+0 VCI DCDA 34 (35+5) 36+2 ElCS F2270/M2370 
5 29+2 VCI DCDA 10 (32+6) 33+0 EmCS M1720/F1730 
6 25+4 VCI & 
PP 
DCDA 30 (28+2) 30+3 EmCS F1240/M1240 
7 23+2 VCI MCDA 30 (34+0) 35+1 ElCS F2910/F2400 
       
 
VCI = velamentous cord insertion; PP = placenta previa; SUA = single umbilical 
artery; DCDA = dichorionic-diamniotic; MCDA = monochorionic-diamniotic; ElCS = 
elective caesarean section; EmCS = emergency caesarean section; F = female; M = 
male.  
 
Table(s)
Table 2. Characteristics of the 13 reports included in the review 
 
Author 
(year) 
Type of study No. of cases of 
VP diagnosed 
antenatally and 
confirmed at 
birth 
No. of twin 
pregnancies 
with VP 
Chorionicity 
Raga et al.25 
(1995) 
Case report 2 1 DCDA 
Nomiyama et 
al.28 
(1998) 
Cohort study of 
VCI (n=6) 
2 1 DCDA 
Lee et al.29 
(2000) 
Cohort study of 
VP 
18 2 N/A 
Francois et 
al.35 
(2003) 
Case-control 
study of VP 
13 1 N/A 
Oyelese et al.6 
(2004) 
Multicenter 
cohort study of 
VP 
155 7 N/A 
Baulies et al.17 
(2007) 
Cohort study of 
VP 
9 2 2 DCDA 
Ghandi et al.26 
2008 
Case report 3 3 3 DCDA 
Chmait et al.27 
(2010) 
Case report 2 1 MCDA 
Smorgick et 
al.30 
(2010) 
Cohort study of 
VP 
19 3 3 DCDA 
Bronsteen et 
al.31 
(2013) 
Cohort study of 
VP 
56 7 N/A 
Rebarber et 
al.32 
(2014) 
Cohort study of 
VP 
29 5 3 DCDA 
2 MCDA 
Swank et al.33 
(2016) 
 
Multicenter 
cohort study of 
VP 
47 5 N/A 
Catanzarite et 
al.34 
(2016) 
Cohort study of 
VP 
92 18 6 DCDA  
12 MCDA 
 
 
VCI = velamentous cord insertion; VP= vasa previa; DCDA= dichorionic-diamniotic; 
MCDA = monochorionic-diamniotic; N/A= not available. 
 
Table 3. Baseline perinatal characteristics of 12 VP cases included in the review   
Author 
(year) 
GA at 
diagnosis  
(wks)  
Other US 
findings 
Chorionicity- 
amnionicity 
CL 
(mm) 
at last 
TVS 
(wks) 
GA at 
delivery 
(wks 
+days) 
Outcome 
Mode of delivery 
Fetal sex & 
weight (g) 
Raga et 
al.25 
(1995) 
 
34 VCI&LLP DCDA N/A 38 ElCS  
M2810/F? 
Nomiyama 
et al.28 
(1998) 
 
18 VCI DCDA N/A 31 EmCS 
F2026/F2030 
 
Lee et 
al.29 
(2000) 
 
N/A 
N/A 
N/A 
N/A 
N/A 
N/A 
N/A 
N/A 
N/A 
27+1 
1 Stillbirth 
1 post-natal death 
 
Baulies et 
al.17 
(2007) 
35 
 
21 
None 
 
VCI 
DCDA 
 
DCDA 
N/A 
 
N/A 
36 
 
34 
EmCS  
F3050/M2210 
ElCS 
F1669/M1990 
 
Ghandi et 
al.26 
(2008) 
29 
18 
19 
None 
VCI&LLP 
VCI&LLP 
DCDA 
DCDA 
DCDA 
N/A 
N/A 
N/A 
34 
34 
35 
ElCS  
ElCS 
ElCS 
 
Chmait et 
al.27 
(2010) 
 
22 TTTS MCDA 11 
(30+5) 
34+3 EmCS 
F2656/1240 
 
Bronsteen 
et al.31 
(2013) 
N/A 
N/A 
N/A 
N/A 
N/A 
N/A 
25 (24) 
15 (28) 
27 
31 
1 post-natal death  
Stillbirth 
 
GA = Gestational age; wks = weeks; VCI = velamentous cord insertion; LLP = low-
lying placenta; SUA = single umbilical artery; DCDA = dichorionic-diamniotic; MCDA 
= monochorionic-diamniotic; TTTS = twin-twin transfusion syndrome; ElCS = elective 
caesarean section; EmCS = emergency caesarean section; F = female; M = male; 
N/A = not available 
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